U.S. News & World Report: Perlmutter Cancer Center Medical Oncologist Discusses Study on Blood Test for Early Cancer Detection

Patient Care, In the Media, Translational Medicine

September 12, 2022

Photo: Jasmin Merdan/Getty

Results of a preliminary study, reported at the 2022 European Society for Medical Oncology Congress, show that a single blood test can screen for more than 50 types of tumors.

Ruth Oratz, MD, a medical oncologist at �ٺ��Ƶ Health’s Perlmutter Cancer Center, tells U.S. News & World Report that it would be “fantastic” to screen for many cancers with a single blood draw.

“This is very exciting technology,” says Dr. Oratz, also a clinical professor in the at NYU Grossman School of Medicine. “But, we’re not there yet.”

�ٺ���Ƶ

Related Articles

Remote Telemedicine Tool Found Highly Accurate in Diagnosing Melanoma

The technology could help address treatment disparities, study authors say.

At the Forefront of Molecular Oncology with Dr. Alec Kimmelman

Looking for “mutations driving the tumor or making it more sensitive to different drugs.”

�ٺ��Ƶ